Celdoxome pegylated liposomal Den europeiske union - norsk - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - doxorubicin hydroklorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastiske midler - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Arimidex 1 mg Norge - norsk - Statens legemiddelverk

arimidex 1 mg

laboratoires juvisé pharmaceuticals - anastrozol - tablett, filmdrasjert - 1 mg

Kimmtrak Den europeiske union - norsk - EMA (European Medicines Agency)

kimmtrak

immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastiske midler - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

Pemetrexed Baxter Den europeiske union - norsk - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastiske midler - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Caelyx pegylated liposomal Den europeiske union - norsk - EMA (European Medicines Agency)

caelyx pegylated liposomal

baxter holding b.v. - doxorubicin hydroklorid - sarcoma, kaposi; multiple myeloma; ovarian neoplasms; breast neoplasms - antineoplastiske midler - caelyx pegylated liposomal er angitt:som monoterapi til pasienter med metastatisk brystkreft, hvor det er en økt kardial risiko;for behandling av avansert eggstokkreft hos kvinner som har mislyktes i et første-linje platinum-basert kjemoterapi diett, i kombinasjon med bortezomib for behandling av progressive myelomatose hos pasienter som har fått minst ett før behandling, og som har gjennomgått eller er uegnet for bein marg transplantasjon, for behandling av aids-relatert kaposis sarkom (ks) hos pasienter med lave cd4 teller (.

Baclofen Sintetica 2 mg/ ml Norge - norsk - Statens legemiddelverk

baclofen sintetica 2 mg/ ml

sintetica gmbh - baklofen - infusjonsvæske, oppløsning - 2 mg/ ml

Baclofen Sintetica 0.5 mg/ ml Norge - norsk - Statens legemiddelverk

baclofen sintetica 0.5 mg/ ml

sintetica gmbh - baklofen - infusjonsvæske, oppløsning - 0.5 mg/ ml

Mallozen 3 mg Norge - norsk - Statens legemiddelverk

mallozen 3 mg

medice arzneimittel pütter gmbh & co kg - melatonin - tablett - 3 mg

Mallozen 2 mg Norge - norsk - Statens legemiddelverk

mallozen 2 mg

medice arzneimittel pütter gmbh & co kg - melatonin - tablett - 2 mg

Mallozen 5 mg Norge - norsk - Statens legemiddelverk

mallozen 5 mg

medice arzneimittel pütter gmbh & co kg - melatonin - tablett - 5 mg